drugset
drugset / Trial / NCT03419910

An Investigational Study of Cyclosporine on Experimental Medication BMS-986165 in Healthy Male Participants

NCT03419910 ↗

Phase 1 Completed 54 enrolled Bristol-Myers Squibb
NaSingle-groupOpen-labelTreatment

Summary

This is an investigational study of Cyclosporine on the experimental medication BMS-986165 in healthy male participants.

Timeline

Start
2018-03-05
Primary completion
2018-05-04
Completion
2018-05-04

Drugs

EvaluationDrugModalityDoseRoute
Subject CRAVACITINIB Small molecule — Oral
Subject Cyclosporine Peptide — Oral

Indications

psoriasis